- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in Lipid Nanoparticles for siRNA Delivery
Authors
Keywords
-
Journal
Pharmaceutics
Volume 5, Issue 4, Pages 498-507
Publisher
MDPI AG
Online
2013-09-18
DOI
10.3390/pharmaceutics5030498
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
- (2013) Martin A Maier et al. MOLECULAR THERAPY
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Safety profile of RNAi nanomedicines
- (2012) Scott A. Barros et al. ADVANCED DRUG DELIVERY REVIEWS
- RNAi-based nanomedicines for targeted personalized therapy
- (2012) Ala Daka et al. ADVANCED DRUG DELIVERY REVIEWS
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
- (2012) Muthusamy Jayaraman et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Superior Penetration and Retention Behavior of 50 nm Gold Nanoparticles in Tumors
- (2012) S. Huo et al. CANCER RESEARCH
- Attacking the genome: emerging siRNA nanocarriers from concept to clinic
- (2012) Christopher Alabi et al. CURRENT OPINION IN PHARMACOLOGY
- Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core
- (2012) Alex K. K. Leung et al. Journal of Physical Chemistry C
- Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA
- (2012) Yuen Yi C. Tam et al. Nanomedicine-Nanotechnology Biology and Medicine
- Gene silencing by chemically modified siRNAs
- (2012) Joachim W. Engels New Biotechnology
- Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
- (2012) Nathan M Belliveau et al. Molecular Therapy-Nucleic Acids
- Unique Gene-Silencing and Structural Properties of 2′-Fluoro-Modified siRNAs
- (2011) Muthiah Manoharan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- In Vivo Delivery of RNAi with Lipid-Based Nanoparticles
- (2011) Leaf Huang et al. Annual Review of Biomedical Engineering
- Current progress of siRNA/shRNA therapeutics in clinical trials
- (2011) John C. Burnett et al. Biotechnology Journal
- Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in Neuroblastoma
- (2011) Daniela Di Paolo et al. MOLECULAR THERAPY
- Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
- (2011) H. Cabral et al. Nature Nanotechnology
- Analysis of lipid nanoparticles by Cryo-EM for characterizing siRNA delivery vehicles
- (2010) Randy Crawford et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
- (2010) Akin Akinc et al. MOLECULAR THERAPY
- Rational design of cationic lipids for siRNA delivery
- (2010) Sean C Semple et al. NATURE BIOTECHNOLOGY
- Synthesis of a Labeled RGD−Lipid, Its Incorporation into Liposomal Nanoparticles, and Their Trafficking in Cultured Endothelial Cells
- (2009) Sonya Cressman et al. BIOCONJUGATE CHEMISTRY
- Novel Cationic Lipid That Delivers siRNA and Enhances Therapeutic Effect in Lung Cancer Cells
- (2009) Yunching Chen et al. MOLECULAR PHARMACEUTICS
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA
- (2008) Shyh-Dar Li et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More